全血储存时间改变了纤维素水平和血栓的形成
Ryan Chae1, Christopher Nguyen, Chad Archdeacon
1From the Department of Surgery, University of Cincinnati, Cincinnati, Ohio.
The journal of trauma and acute care surgery
|March 27, 2024
概括
在老年全血中,微小血管增加了血栓的生成,在创伤复苏期间影响了血静. 阻断微粒细胞上的脂素部分降低了这种前凝效应.
科学领域:
- 输血医学 输血医学
- 血液静止和血栓形成
- 创伤复苏 创伤复苏
背景情况:
- 全血复苏对于出血性休克至关重要,提供红细胞和纠正凝血病.
- 在储存的全血中微粒的作用及其对静血参数的影响仍未得到充分描述.
- 陈旧的全血中的微小囊被假设是前凝剂,通过脂胺激素增强血栓的产生.
研究的目的:
- 为了研究储存的全血中微粒细胞的前凝效应.
- 确定微微囊影响血栓生成的机制.
- 为了评估微微囊在冷藏期间对静血参数的影响.
主要方法:
- 鼠全血存储时间长达10天,并定期分析旋转性血栓形成和血栓生成.
- 从老化的全血中分离出微,并添加到新鲜血液或血中,以评估凝血变化.
- 在添加到血之前,通过用乳腺治疗微粒细胞来评估酸的作用.
主要成果:
- 与新鲜样本相比,老化全血显示纤维素凝块形成减少和纤维素原水平较低.
- 从老化血液中的血中产生血栓素随着储存时间的增加而增加.
- 从老化血液中获得的微细胞显著增加了新鲜血中的血栓生成;当阻断脂素时,这种效应会减弱.
结论:
- 整个血液的冷储导致纤维素素的减少和凝块的形成受损.
- 在老年全血中增加的血栓生成部分归因于微粒细胞的产生.
- 微粒细胞上的酸酶表达有助于它们在储存的全血中产生血凝活动.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
690
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
690
Extrinsic and Intrinsic Pathways of Hemostasis
7.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.5K
Coagulation
6.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.5K


